---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009859"
form_type: "8-K"
ticker: null
cik: "0001138978"
company_name: "Novo Integrated Sciences, Inc."
filed_at: "2025-03-11T23:59:59+00:00"
generated_at: "2026-05-24T23:14:14.150297+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Novo Integrated Sciences extends CEO resignation to March 31, 2025; Mattacchione to stay as Chairman

## Summary
- CEO Robert Mattacchione's resignation, previously set for February 5, 2025 and extended twice, now extended to no later than March 31, 2025.
- After stepping down as CEO, Mattacchione will remain Chairman of the Board and Chairman of subsidiary Novo Healthnet Limited.
- Resignation is not due to any disagreement with company operations, policies, or practices.

## SEC filing metadata
- accession: 0001493152-25-009859
- form_type: 8-K
- cik: 0001138978
- company_name: Novo Integrated Sciences, Inc.
- filed_at: 2025-03-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1138978/000149315225009859/0001493152-25-009859-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1138978/000149315225009859/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009859
- JSON: https://secwatch.observer/filing/0001493152-25-009859.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009859.txt

## Key facts
- Executive change
  Robert Mattacchione resigned as Chief Executive Officer at Novo Integrated Sciences, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: Following Mr. Mattacchione’s departure as Chief Executive Officer, Mr. Mattacchione intends to continue to serve as (i) the Company’s Chairman of the Board, and (ii) Chairman of Novo Healthnet Limited, a wholly owned subsidiary of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1138978/000149315225009859/0001493152-25-009859-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
